63194-69-4 Usage
Uses
Used in Pharmaceutical Applications:
Asarinin is used as a potential therapeutic agent for various conditions due to its anti-inflammatory, antioxidant, and neuroprotective properties. It is being investigated for its ability to alleviate inflammation, counteract oxidative stress, and protect neurons from damage, which could be beneficial in treating a range of diseases and disorders.
Used in Antitumor Applications:
Asarinin is also being explored for its potential antitumor activity. It may be used as a compound in the development of new cancer treatments, particularly if its antitumor properties can be effectively harnessed and delivered to target cancer cells.
Used in Medicinal Chemistry Research:
Asarinin's unique chemical structure and properties make it a valuable subject for further research in medicinal chemistry. Scientists are interested in understanding its mechanisms of action and how it can be modified or used in the development of new drugs with improved efficacy and fewer side effects.
Used in Phytochemistry Studies:
In the field of phytochemistry, asarinin is used as a key compound for studying the chemical constituents of plants from the Asarum genus and Abelmoschus esculentus. Understanding the properties and potential applications of asarinin can contribute to the broader knowledge of plant-based medicines and their therapeutic uses.
Check Digit Verification of cas no
The CAS Registry Mumber 63194-69-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,1,9 and 4 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 63194-69:
(7*6)+(6*3)+(5*1)+(4*9)+(3*4)+(2*6)+(1*9)=134
134 % 10 = 4
So 63194-69-4 is a valid CAS Registry Number.
63194-69-4Relevant academic research and scientific papers
Trost, Barry M.,Zuo, Zhijun
, p. 1243 - 1247 (2020)
A novel Pd0-catalyzed asymmetric [4+3] annulation reaction of two readily accessible starting materials has been developed for building seven-membered heterocyclic architectures. The potential [3+2] side pathway could be suppressed though fine tuning of the conditions. A broad scope of cycloaddition donors and acceptors participated in the transformation with excellent chemo-, regio-, diastereo-, and enantioselectivtities, leading to valuable tetrahydroazepines and benzo[b]oxepines.
Enantioselective γ-Addition-Driven Cascade of β,γ-Unsaturated Ketones by Ion-Pair Catalysis: Access to Chiral 1,3-Dioxolochroman Scaffolds
Wang, Xuemei,Zhou, Liang,Zhang, Hongkui,Ren, Xiaoyu,Gao, Guowei,Wang, Tianli
supporting information, p. 38 - 42 (2022/01/04)
A highly enantioselective γ-addition-driven cascade of β,γ-unsaturated carbonyl compounds by bifunctional ion-pair catalysis has been developed. With this protocol, a range of functionalized chiral 1,3-dioxolochroman derivatives were prepared in high yields with superior stereoselectivities (>99% ee and >20:1 dr). The utility of this method was demonstrated by one-pot synthesis, scaled-up preparation, and facile transformation. Moreover, mechanistic investigations provided insights into the reaction pathway and the origin of chiral induction.
